10-K: Axcelis Reports 2025 Revenue Decline Amid Merger Progress

Axcelis Technologies reports a significant decrease in 2025 revenue and net income, while advancing its merger with Veeco Instruments and navigating U.S. export controls.

Summary

• Total revenue for 2025 was $839.0 million, a decrease from $1,017.9 million in 2024.
• Net income for 2025 was $120.2 million, down from $201.0 million in 2024.
• Diluted earnings per share (EPS) for 2025 was $3.80, compared to $6.15 in 2024.
• Gross margin percentage slightly increased to 44.9% in 2025 from 44.7% in 2024, driven by a higher mix of parts and upgrades.
• Operating profit decreased to $119.3 million in 2025 from $210.8 million in 2024.
• Aftermarket (CS&I) revenue grew to $268.0 million in 2025 from $235.3 million in 2024.
• Systems backlog decreased to $457.0 million as of December 31, 2025, from $645.8 million in 2024.
• The merger with Veeco Instruments Inc. is progressing, with Axcelis stockholders approving the Company Stock Issuance on February 6, 2026, but remains subject to Chinese regulatory approval.
• Research and development expenses increased to $109.0 million in 2025, representing 13.0% of revenue.
• General and administrative expenses increased by 18.3% to $83.2 million, primarily due to $16.3 million in merger-related professional and filing fees.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with caution due to significant declines in key financial metrics like revenue and net income, coupled with the uncertainties and costs associated with the pending Veeco merger and ongoing export control risks. While aftermarket growth and strong customer satisfaction are positives, they are overshadowed by the overall financial downturn.

Positives

• Gross margin percentage slightly improved to 44.9% in 2025, up from 44.7% in 2024, primarily due to an increased mix of higher-margin parts and upgrades.
• Aftermarket (Customer Solutions & Innovation) revenue increased to $268.0 million in 2025 from $235.3 million in 2024, demonstrating growth in recurring service and parts business.
• The company maintained its position as a technology leader and supplier of choice in the implant-intensive power device segment, which accounted for 55% of 2025 system shipments.
• Axcelis received 16 customer satisfaction awards in 2025 and was named to Forbes List of America's Best Mid-Cap Companies and Fortune Magazine's Top 100 Fastest Growing Companies in 2024.
• Cash and cash equivalents increased to $145.5 million at December 31, 2025, from $123.5 million at December 31, 2024, and the company has no bank debt.
• Voluntary employee turnover rate was 7.4% (5.0% without retirements) in 2025, below the worldwide technology industry average of 11.7%, indicating strong employee retention.
• Axcelis stockholders approved the Company Stock Issuance for the merger with Veeco Instruments Inc. on February 6, 2026, a key milestone for the transaction.

Negatives

• Total revenue decreased significantly to $839.0 million in 2025 from $1,017.9 million in 2024, an 17.6% decline.
• Net income fell to $120.2 million in 2025 from $201.0 million in 2024, a 40.2% decrease.
• Diluted earnings per share (EPS) decreased to $3.80 in 2025 from $6.15 in 2024.
• Operating profit declined to $119.3 million in 2025 from $210.8 million in 2024.
• Systems revenue, which includes new system sales, decreased to $571.0 million in 2025 from $782.6 million in 2024, primarily due to a decrease in the number of Purion systems sold.
• Systems backlog decreased to $457.0 million as of December 31, 2025, from $645.8 million as of December 31, 2024, indicating lower future revenue visibility.
• Service gross margin was negative (5.1%) in 2025, compared to 5.4% in 2024, attributed to changes in service contract mix and fluctuations in service expenses.
• General and administrative expenses increased by 18.3% to $83.2 million, largely due to $16.3 million in merger-related professional and filing fees.

Risks

• Sales and profitability will be harmed if semiconductor chip manufacturers do not make sufficient capital expenditures, as new systems orders and used tool sales depend on demand for fabrication facility construction or expansion.
• Failure to develop and introduce reliable new or enhanced products and services that meet customer needs could adversely affect results, given rapid technological changes in semiconductor chip manufacturing.
• Substantial dependence on international sales (83.7% of 2025 revenue), particularly from Asia, exposes the company to risks from changes in laws, regulations, tariffs, currency exchange rates, political/economic instability, and global health emergencies.
• Increased U.S. export controls on shipments to Chinese customers, including SMIC being on the U.S. Entity List, pose a higher risk to revenue from China due to trade tensions and potential supplier changes to non-U.S. vendors.
• Dependence on a limited group of suppliers for many components and sub-assemblies could result in increased costs or delays in manufacturing and sales, negatively impacting gross margin.
• A significant portion of revenue depends on customers electing to buy aftermarket products and services from Axcelis; competition from third-party suppliers or customers performing their own maintenance could reduce revenue and profitability.
• Failure to compete successfully in the highly competitive semiconductor capital equipment industry, which includes a competitor with substantially greater resources (Applied Materials) and smaller innovative companies, could lead to declining sales and profitability.
• Dependence on a limited number of large customers (top ten accounted for 55.2% of net sales in 2025) means the loss or reduction of orders from any significant customer could materially affect sales.
• International operations involve currency risk, as fluctuations in exchange rates can impact reported revenues, expenses, profitability, and asset values, particularly for non-U.S. dollar denominated transactions.
• Inability to hire, retain, and integrate qualified personnel, especially skilled engineers, could limit growth, lead to missed delivery commitments, or decrease customer satisfaction.
• Financial results may fluctuate significantly due to the sale of a small number of expensive products to a limited customer base, changes in product mix, and fixed expenses.
• Forecasting revenue and profitability is complex and may be inaccurate due to lengthy sales cycles, competing capital budget considerations, and revenue recognition complexities, potentially leading to financial results falling short of anticipated levels.
• The cyclical nature of the semiconductor industry, with upturns and downturns in demand, makes business management difficult and can disproportionately affect profitability due to a substantial portion of fixed operating expenses.
• Exposure to cybersecurity threats and incidents, including unauthorized data exfiltration or system disruption, could result in business disruption, data loss, reputational damage, litigation, and increased costs.
• Risks associated with compliance with environmental, health, and safety regulations could result in significant liabilities, penalties, restrictions on operations, or decreased asset value.
• Proprietary technology may be vulnerable to competitors challenging or designing around patents, potentially reducing market share and requiring costly litigation to enforce intellectual property rights.
• Potential intellectual property infringement claims or patent disputes, including those for which Axcelis indemnifies customers, could be costly to resolve and prevent the company from making and selling systems.
• Disruption at Axcelis manufacturing facilities (Beverly, MA and South Korea) due to severe weather, natural disasters, work stoppages, or terrorism could cause shipment delays, order cancellations, or customer loss.
• Inability to access capital on favorable terms, on anticipated timelines, or at all, could materially adversely affect financial condition and results of operations, potentially requiring curtailment of operations or asset disposal.
• The market price of common stock may be volatile due to variations in quarterly results, analyst estimates, market valuations of similar companies, significant announcements, loss of major customers, personnel changes, and ESG initiatives.
• Operating in jurisdictions with complex and changing tax laws, such as the U.S. One Big Beautiful Bill Act (OB3) and corporate tax reform, could impact tax liability and results of operations.
• The fixed exchange ratio in the Veeco merger agreement means the merger consideration will not be adjusted for changes in either Axcelis or Veeco's stock price, potentially affecting the value received by stockholders.
• The merger may be delayed or not completed due to conditions such as regulatory approvals (e.g., China's State Administration for Market Regulation), absence of governmental restraints, or material adverse effects on either party, leading to significant costs and business disruptions.
• Stockholders of both Axcelis and Veeco will have reduced ownership and voting interest in the combined company post-merger.
• The merger agreement restricts Axcelis and Veeco from certain transactions and actions prior to completion, potentially preventing them from pursuing beneficial opportunities.
• Litigation challenging the merger could prevent or delay its completion or result in damages.
• Failure to attract, motivate, and retain executives and other key employees during and after the merger could diminish anticipated benefits and harm the combined company's business.

Future Outlook

Axcelis expects to continue delivering consistent, profitable financial performance in 2026, subject to industry risks. The merger with Veeco Instruments Inc. is anticipated to be completed in the second half of 2026, pending final regulatory approval from China. The company projects total capital expenditures for 2026 to be approximately $18 million and plans to file another shelf registration statement to maintain financing options beyond August 2026.

Management Comments

• "We believe that our Purion family of products offers the most innovative implanters available on the market today."
• "A focused strategy on ion implant, combined with the hard work and dedication of our employees and the support of our customers and suppliers, enabled us to achieve critical milestones in our drive to market leadership."
• "We continued working to expand our footprint with existing and new customers and currently have four Purion evaluation systems in the field at strategic customer sites in key market segments."
• "We continued our investment in our Customer Solutions & Innovation (CS&I) aftermarket business to drive financial growth and increased customer satisfaction levels, including the Digital Tool Box, an innovative service offering with online training, remote diagnosis and install, and automated troubleshooting guide."
• "We continue to work diligently to ensure that manufacturing and operating expense levels remain well aligned to business conditions. We believe that the most fundamental interest of our stockholders is consistent, profitable financial performance, which we expect to continue to deliver in 2026."
• "Our goal is to avoid any actions which may be, or even appear to be, ethical violations or conflicts of interest."
• "We strongly encourage employees who are considering actions which in any way raise ethical concerns to discuss their options with supervisors, members of the Human Resources team and/or our General Counsel."
• "Axcelis understands that employees may be reluctant to complain of ethical violations or conflicts of interest or to cooperate with an investigation for fear of retaliation, and Axcelis will take action to protect those employees. Any type of retaliation is strictly prohibited and will result in disciplinary action, up to and including termination of employment."

Industry Context

StockSavvy.ai notes that Axcelis's performance reflects the cyclical nature of the semiconductor capital equipment industry, which experienced a downturn in 2025. Despite a general decline in capital spending by top manufacturers (down to 86.4% from 87.6% in 2024), Axcelis's growth in aftermarket services and strong position in the power device segment (55% of system shipments) indicate resilience in specific niches. The ongoing U.S. export controls to China continue to reshape the competitive landscape, potentially favoring non-U.S. suppliers like Sumitomo Heavy Industries Ion Technology Co. Ltd. and Nissin Ion Equipment Co., Ltd., while also fostering domestic Chinese competitors such as Kingstone Semiconductor and CETC Electronics Equipment Group Co., Ltd. The proposed merger with Veeco Instruments Inc. signals a strategic move towards consolidation and expanded market presence in a highly competitive environment.

Comparison to Industry Standards

• Axcelis's voluntary employee turnover rate of 7.4% (5.0% excluding retirements) in 2025 is significantly below the worldwide technology industry average of 11.7% reported in the Aon 2025 Salary Increase and Turnover Study, indicating superior employee retention compared to industry benchmarks.
• The company's focus on the implant-intensive power device segment, accounting for 55% of 2025 system shipments, positions it strongly in a growing area driven by electric vehicles and industrial applications, aligning with broader industry trends towards electrification and advanced materials like SiC wafers.
• Axcelis's receipt of 16 customer satisfaction awards in 2025 and recognition on Forbes' List of America's Best Mid-Cap Companies and Fortune Magazine's Top 100 Fastest Growing Companies (2024 editions) suggests strong customer relationships and market perception, which are critical competitive advantages in the semiconductor equipment sector, where competitors like Applied Materials, Inc. also vie for market leadership.

Management Changes

Corporate Governance

Legal Proceedings

• Not presently a party to any litigation believed to have a material adverse effect on business operations.
• From time to time, the company is a party to litigation arising in the normal course of business operations.

Related Party Transactions

• No significant related-party transactions requiring disclosure in the consolidated financial statements for the year ended December 31, 2025, or in this Annual Report on Form 10-K.

Stakeholder Impact

• **Shareholders:** Experienced a significant decrease in diluted EPS ($3.80 in 2025 vs. $6.15 in 2024) and face potential stock price volatility due to overall financial performance, the ongoing Veeco merger, and broader market conditions. The merger will result in reduced ownership and voting interest in the combined company. The stock repurchase program returned value to shareholders, with $121.1 million used in 2025.
• **Employees:** The company maintains competitive compensation and benefits, training programs, and flexible work opportunities. High employee retention (7.4% voluntary turnover, 5.0% without retirements) indicates a positive work environment. However, the pending merger could create uncertainty regarding future roles and integration.
• **Customers:** Benefited from continued investment in the Customer Solutions & Innovation (CS&I) aftermarket business, including the Digital Tool Box, and the company received 16 customer satisfaction awards. However, U.S. export controls, particularly concerning China, pose risks to product availability for certain customers.
• **Suppliers:** Subject to a Supplier Code of Conduct, requiring compliance with environmental and social responsibility policies. The company's dependence on a limited group of suppliers for critical components creates a risk of increased costs or delays, potentially impacting product delivery.
• **Creditors:** The company has no bank debt and maintains a strong liquidity position with $145.5 million in cash and cash equivalents, indicating a low credit risk profile. Contractual obligations and commercial commitments are disclosed, with sufficient cash and investments to satisfy anticipated requirements.

Next Steps

• Complete the merger with Veeco Instruments Inc., pending final regulatory approval from the State Administration for Market Regulation of the People's Republic of China, expected in the second half of 2026.
• Continue to build the foundation on the long-term implant-only business model, including winning new customers with Purion products and aftermarket offerings.
• Improve customer satisfaction to drive repeat business.
• Execute on identified growth opportunities in Japan and advanced logic.
• Deliver Customer Solutions & Innovation (CS&I) target business model revenues of approximately 25% of total revenues.
• Drive profitable growth by focusing on key customers and targeted market/geographic segments.
• Achieve market share leadership across all served markets.
• Deliver attractive earnings per share and cash generation as defined in targeted business models.
• Monitor spending in line with growth initiatives and industry trends.
• Execute capital strategy that allows for appropriate business investments while returning value to shareholders.
• Increase gross margins by deriving maximum value from enabling upgrades, system specials, and product extensions while lowering cost through Design for X (DFx) principles, right sourcing, and providing industry's best products and services.
• Expand beyond ion implant by launching identified corporate development growth initiatives.
• Invest in research and development to ensure products meet customer needs and add to the portfolio of patents and proprietary technology.
• Maintain operational excellence by focusing on lowering product, manufacturing, and design costs and improving delivery times.
• Generate strong cash flows from operations and maintain a sufficient cash balance to fund business growth.
• Project approximately $18 million in capital expenditures for 2026.
• Potentially file another shelf registration statement to maintain the availability of financing options beyond August 2026.

Key Dates

Recommendation

Axcelis Technologies' 2025 results show a significant decline in revenue and net income, reflecting a challenging semiconductor capital equipment market. While the growth in aftermarket services and a strong position in the power device segment are positive, the overall financial downturn and the uncertainties surrounding the Veeco merger, particularly the pending Chinese regulatory approval, introduce considerable risk. The company's strong cash position and commitment to R&D provide a foundation, but the near-term outlook is clouded by integration costs and potential market volatility. A 'hold' recommendation is appropriate, acknowledging the strategic potential of the merger and resilience in certain business areas, but advising caution due to the current financial headwinds and execution risks.

Keywords

Semiconductor Equipment, Ion Implantation, Axcelis Technologies, ACLS, Veeco Instruments, Merger, SEC Filing, 10-K, Financial Results, Aftermarket Services, Purion, Power Device, Export Controls, China Trade, Corporate Governance, Risk Factors, Semiconductor Industry, Capital Equipment, ESG